Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study.

ABSTRACT:

Background

Clinical guidelines in the UK and elsewhere do not specifically address hybrid closed loop (HCL) use in the postpartum period when the demands of caring for a newborn are paramount. Our aim was to evaluate the safety and efficacy of HCL use during the first 6 months postpartum compared with standard care.

Methods

In this prespecified extension to a multicentre, randomised controlled trial, pregnant women with type 1 diabetes at nine UK sites were followed up for 6 months postpartum. Eligible participants (AiDAPT participants recruited after the implementation of the postpartum protocol amendment approval, those still pregnant or within six months of delivery at the time of amendment implementation and still using HCL or continuous glucose monitoring [CGM] therapy)

SUBMITTER: Lee TTM 

PROVIDER: S-EPMC7617783 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature